Literature DB >> 30953305

Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California : Mind the Gaps: Cobertura de recetas e incidencia de VIH entre pacientes recibiendo profilaxis pre-exposición de un centro de salud grande y federalmente calificado en Los Ángeles, CA.

Chelsea L Shover1,2,3, Steven Shoptaw4, Marjan Javanbakht5, Sung-Jae Lee5,6, Robert K Bolan7, Nicole J Cunningham7, Matthew R Beymer7,8, Michelle A DeVost7,9, Pamina M Gorbach5,8.   

Abstract

We conducted a records-based cohort study of patients who initiated pre-exposure prophylaxis (PrEP) at a large federally qualified health center in Los Angeles, CA to characterize patterns of PrEP use, identify correlates of PrEP discontinuation, and calculate HIV incidence. Of 3121 individuals initiating PrEP between 2014 and 2017, 42% (n = 1314) were active (i.e., had a current PrEP prescription) in April 2018. HIV incidence was 0.1/100 person-years among active PrEP patients, compared to 2.1/100 person-years among patients who discontinued. Compared to patients accessing PrEP through government programs with no prescription copay, risk of discontinuation was higher among those with private insurance (ARR = 1.4, 95% CI 1.2, 1.7), or no insurance (ARR = 4.5, 95% CI 3.2, 6.4). Sixty-three percent of active PrEP patients had gaps between PrEP prescriptions, averaging one gap per year (median length = 65 days). Increasing access to free or low-cost PrEP can improve PrEP continuity.

Entities:  

Keywords:  HIV incidence; HIV prevention; Health insurance; Pre-exposure prophylaxis

Mesh:

Substances:

Year:  2019        PMID: 30953305      PMCID: PMC6863609          DOI: 10.1007/s10461-019-02493-w

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  23 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.

Authors:  Sybil G Hosek; Bret Rudy; Raphael Landovitz; Bill Kapogiannis; George Siberry; Brandy Rutledge; Nancy Liu; Jennifer Brothers; Kathleen Mulligan; Gregory Zimet; Michelle Lally; Kenneth H Mayer; Peter Anderson; Jennifer Kiser; James F Rooney; Craig M Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

3.  HIV Preexposure Prophylaxis Initiation at a Large Community Clinic: Differences Between Eligibility, Awareness, and Uptake.

Authors:  Chelsea L Shover; Marjan Javanbakht; Steven Shoptaw; Robert K Bolan; Sung-Jae Lee; Jeffrey T Parsons; Jonathon Rendina; Pamina M Gorbach
Journal:  Am J Public Health       Date:  2018-08-23       Impact factor: 9.308

4.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Authors:  Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

5.  Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012-2017: Are Quarterly Visits Too Much?

Authors:  Laura K Rusie; Carlos Orengo; Diane Burrell; Arthi Ramachandran; Magda Houlberg; Kristin Keglovitz; David Munar; John A Schneider
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

6.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

7.  HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic.

Authors:  J Carlo Hojilla; David Vlahov; Pierre-Cedric Crouch; Carol Dawson-Rose; Kellie Freeborn; Adam Carrico
Journal:  AIDS Behav       Date:  2018-04

8.  Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study.

Authors:  Steven M Goodreau; Deven T Hamilton; Samuel M Jenness; Patrick S Sullivan; Rachel K Valencia; Li Yan Wang; Richard L Dunville; Lisa C Barrios; Eli S Rosenberg
Journal:  J Adolesc Health       Date:  2017-12-13       Impact factor: 5.012

9.  Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis delivery.

Authors:  Heather A Pines; Pamina M Gorbach; Robert E Weiss; Steve Shoptaw; Raphael J Landovitz; Marjan Javanbakht; David G Ostrow; Ron D Stall; Michael Plankey
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

10.  Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.

Authors:  Philip A Chan; Leandro Mena; Rupa Patel; Catherine E Oldenburg; Laura Beauchamps; Amaya G Perez-Brumer; Sharon Parker; Kenneth H Mayer; Matthew J Mimiaga; Amy Nunn
Journal:  J Int AIDS Soc       Date:  2016-06-13       Impact factor: 5.396

View more
  19 in total

1.  Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation.

Authors:  Matthew A Spinelli; Susan P Buchbinder
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

Review 2.  How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?

Authors:  Urvi M Parikh; John W Mellors
Journal:  Curr Opin HIV AIDS       Date:  2022-07-01       Impact factor: 4.061

3.  Risk Factors Associated with Loss to Follow-up Among Transgender Women Receiving HIV Pre-exposure Prophylaxis in Chiang Mai province, Thailand.

Authors:  Natthapat Thongsak; Natthaporn Manojai; Rathawit Apiputhipan; Nicha Rongram; Natnita Mattawanon; Walaithip Bunyatisai; Bandhita Plubin; Nawapon Nakharutai; Salinee Thumronglaohapun; Pimwarat Srikummoon; Kanokkan Wongsawat; Patrinee Traisathit; Nontiya Homkham
Journal:  AIDS Behav       Date:  2022-08-05

4.  Are Unequal Policies in Pre-Exposure Prophylaxis Uptake Needed to Improve Equality? An Examination Among Men Who Have Sex with Men in Los Angeles County.

Authors:  Anthony Nguyen; Emmanuel Fulgence Drabo; Wendy H Garland; Corrina Moucheraud; Ian W Holloway; Arleen Leibowitz; Sze-Chuan Suen
Journal:  AIDS Patient Care STDS       Date:  2022-08       Impact factor: 5.944

5.  Using Microsimulation Modeling to Inform EHE Implementation Strategies in Los Angeles County.

Authors:  Emmanuel F Drabo; Corrina Moucheraud; Anthony Nguyen; Wendy H Garland; Ian W Holloway; Arleen Leibowitz; Sze-Chuan Suen
Journal:  J Acquir Immune Defic Syndr       Date:  2022-07-01       Impact factor: 3.771

6.  Texting Lost-to-follow-up PrEP Patients from a San Francisco Sexual Health Clinic.

Authors:  Kelly A Johnson; Montica Levy; Hannah Brosnan; Robert P Kohn; Stephanie E Cohen
Journal:  Prev Sci       Date:  2022-07-16

Review 7.  Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.

Authors:  Sarah E Rutstein; Dawn K Smith; Shona Dalal; Rachel C Baggaley; Myron S Cohen
Journal:  Lancet HIV       Date:  2020-08-27       Impact factor: 12.767

8.  "It's Very Inconvenient for Me": A Mixed-Method Study Assessing Barriers and Facilitators of Adolescent Sexual Minority Males Attending PrEP Follow-Up Appointments.

Authors:  Christopher Owens; Kevin Moran; Melissa Mongrella; David A Moskowitz; Brian Mustanski; Kathryn Macapagal
Journal:  AIDS Behav       Date:  2021-06-03

9.  Structural, Dosing, and Risk Change Factors Affecting Discontinuation of Pre-exposure Prophylaxis (PrEP) in a Large Urban Clinic.

Authors:  Chelsea L Shover; Michelle A DeVost; Nicole J Cunningham; Matthew R Beymer; David Flores; Risa Flynn; Pamina M Gorbach; Phoebe Lyman; K Rivet Amico; Robert K Bolan
Journal:  AIDS Educ Prev       Date:  2020-08

10.  Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.

Authors:  F Hovaguimian; E Martin; M Reinacher; M Rasi; A J Schmidt; E Bernasconi; E Boffi El Amari; D L Braun; A Calmy; K Darling; V Christinet; C Depmeier; C Hauser; S Läuchli; J Notter; M Stoeckle; B Surial; P Vernazza; P Bruggmann; P Tarr; D Haerry; R Bize; N Low; A Lehner; J Böni; R D Kouyos; J S Fehr; B Hampel
Journal:  HIV Med       Date:  2021-10-03       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.